Article Text
Abstract
Background Endometriosis is a chronic disease that affects women in reproductive age, and adenomyosis was known as “endometriosis in the uterus”. Endometriosis is an immune-dysfunction-related disease, contributing to the diversity of microbiota in the lower genital tract. Endometriosis is also an infection-related disease, the number of bacteria may contribute to some unknown mechanisms. Presently, the feature of microbiota between endometriosis patients and normal people is not fully understood.
Methods To identify the microbiota differences and features of endometriosis patients, 298 samples from the cervical canal, posterior fornix of the vagina and uterine cavity were analyzed by 16s-rRNA sequencing. Raw data were filtered, analyzed, and visualized. We conducted diversity analysis, statistical data of microbiota abundance, biomarker identification, random forest, and environmental factors analysis.
Results Alpha diversity was not distinctive in endometriosis and adenomyosis patients. Posterior fornix near cervix was a better sampling location to analyze the dysmenorrhea-related microbiota feature; few dysmenorrhea-related bacteria were identified. Endometrial bacteria is controversial, and the result of 16s-rRNA sequencing was not good enough to conduct further analysis. Anaerococcus was a possible biomarker of adenomyosis-endometriosis patients. The identified bacteria were representative only in specific periods during the menstrual cycle. GnRH-a treatment impacted microbiota feature the most compared with other environmental factors.
Conclusion This study provided us with a new concept of endometriosis and bacteria; different microbiota features may relate to endometriosis. The bacterial involvement should be considered in the future study of endometriosis. New non-invasive diagnosis and therapeutic methods through bacterial medication are prospective.
Highlights
This paper focused on the microflora associated with the lower reproductive tract of patients with endometriosis and adenomyosis in northern China.
Sampling and comparison were made in two parts (cervical canal and posterior fornix) in the study. It was proved that posterior fornix of vagina was a better site to analyze dysmenorrhea.
A few bacteria were identified as important microbiota in different phases of menstrual cycle. GnRH-a treatment was a critical factor that influence the microbiota feature.
Anaerococcus was defined as the biomarker of adenomyosis-endometriosis patients, in both family and genus level.
- Endometriosis
- Adenomyosis
- Microbiome
- Bio-marker
- 16s rRNA sequencing
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Statistics from Altmetric.com
1 Introduction
Endometriosis is a chronic gynecological disorder characterized by endometrial tissue outside the uterus and affects 10–15 % of women in reproductive age.1–4 Endometriosis contributes a lot to pelvic pain, ovarian mass, and infertility.1,5 In addition, adenomyosis, which is known as “endometriosis of the uterus”, an important gynecological disorder and causes severe pelvic pain6,7, but their interrelations is not fully understood.6 Immunological disorder, angiogenesis and endocrine are closely related to the development of endometriosis. H.Kobayashi has reported that Neurotrophins (NTs) are overexpressed in endometriosis and encompass nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and NT-3 and NT-4/5, An increased release of proinflammatory cytokines from endometriotic lesions is contribute to the excessive sensory innervation and development of chronic pelvic pain8. Immune system dysfunction greatly impacts the development of endometriosis, which involves various types of immune cells and cytokines.1,9 The feature of the host immunity is also closely related to bacterial vaginosis (BV),10 previous studies had demonstrated that infection of the genital tract might be associated with endometriosis, lipopolysaccharide regulates the pro-inflammatory response and the growth of endometriosis through the LPS/TLR4 cascade. Besides, the cross-talk between inflammation and ovarian steroids or the stress reaction also was observed in the pelvic peritoneum.11,12 Menstrual cycle-related taxa are over-represented in endometriosis and adenomyosis patients.13
Bacterial vaginosis (BV) is best described as a polybacterial dysbiosis,14 and it is correlated to immune dysfunction.15,16 Numbers of evidence suggested that endometriosis was associated with bacterial infection and lipopolysaccharide.10,16,17 The related bacteria may rise from the vaginal to the uterine cavity, but the exact mechanism is still unrevealed. Human Microbiome Project (HMP) is aimed to recognize the importance of bacterial community in human health.17 Since the 16s-ribosome RNA sequencing technology was developed, much more bacteria were identified because culture-based technology can only culture finite live bacteria while approximately 1 % of bacteria can be culture.18 HMP project had been conducted in many different aspects, including urine, fetal-amniotic fluid-maternal host, digestion tract, and human skin17–24. Some researchers even performed the gut microbiome analysis in endometriosis mice25; however, there is only a few studies on the microbiome of endometriosis or adenomyosis in the female genital tract. Chen et al. conducted the random forest models distinguished depletion or enrichment of many bacteria subjected to diseases.13 The results were relatively debatable for those who had previously demonstrated the possible microbiome features in endometriosis patients. A large cohort study had revealed that BV is positively correlated to endometriosis,26 but the BV-related Atopobium was found depletion.27
It is important to investigate the microbiome in endometriosis and adenomyosis patients. We can alleviate endometriosis by regulating vaginal bacterial if the exact functions of the microbiome are identified in the future.
2 Materials and methods
2.1 Patient selection
This study was approved by Ethics Committee of Peking Union Medical College Hospital (PUMCH), approval No. JS-1532. The outpatients in clinical visit and inpatients who were hospitalized for surgery were included in the study from April 2018 to May 2019. The inclusion criteria include: regular menstrual cycle (28 ± 7 days), age range from 18 to 45-year-old, antibiotic-free within 30 days, no trans-vaginal intercourse within 2 days, no douching and trans-vaginal medications within 5 days, no cervical treatment within 7 days. The exclusion criteria include: participants with symptomatic BV, cervicitis, pelvic inflammatory disease (PID), any acute systemic inflammation, malignancy, autoimmune disorders, pregnancy, and intrauterine devices, oral-contraceptive treatment in 30 days, during menstruation. Informed consent was obtained from all participants.
149 participants were included in this study, and 298 samples were available totally. Cervical canal (site-A) and posterior fornix (site-B) samples were collected from each participant, and the data of 147 samples from the cervical canal (site-A) and 146 samples from posterior fornix (site-B) were available eventually. 7 samples from the uterine cavity (site-C) were collected, and 5 (71.43 %) of them generated available data successfully (Fig. 1 a). Considering the small sample size and low PCR quality, intra-uterine samples were excluded temporally. 134 participants underwent surgery intervention, with traceable surgery records and pathological reports. While the other 15 outpatients did not undergo surgery intervention, and their final diagnoses were obtained from radiological examinations (magnetic resonance images and ultrasounds).
2.2 Sample collection
Disposable swabs (Jiangsu Tianli Medical Instrument CO., LTD.) were used for cervical sampling canal (site A), and posterior fornix of the vagina (site B); vacuum suck tubes (Jiangsu Tianli Medical Instrument CO., LTD. Guardking, JDC-II) were used for sampling endometrium (site C). All the samples were then placed in ice and subsequently stored at −80 °C, then transported on dry ice to Annoroad Gene Technology Co. Ltd (Beijing, China) for further analysis.
2.3 16S ribosomal-RNA gene sequencing
Total genome DNA from samples was extracted using CTAB/SDS method (E.Z.N.A.® soil DNA Kit, Omega Bio Tek, Norcross, GA, U.), according to manufacturer's protocols. DNA concentration and purity were evaluated by NanoDrop 2000 UV vis spectrophotometer (Thermo Scientific, Wilmington, USA). 16S rRNA genes of distinct regions (16SV3–V4) were amplified used specific primers 338F (5′-ACTCCTACGGGAGGCAGCAG-3′) and 806R (5′-GGACTACHVGGGTWTCTAAT-3′) with the barcode. All PCR reactions were carried out with Phusion® High-Fidelity PCR Master Mix (New England Biolabs). Samples with the bright main strip between 400 and 450bp were selected for further experiments. PCR products were mixed in equidensity ratios. Then, mixture PCR products were purified with Qiagen Gel Extraction Kit (Qiagen, Germany). Sequencing libraries were generated using TruSeq® DNA PCR-Free Sample Preparation Kit (Illumina, USA) following the manufacturer's recommendations, and index codes were added. The library quality was assessed on the Qubit@ 2.0 Fluorometer (Thermo Scientific) and Agilent Bioanalyzer 2100 system. Lastly, the library was sequenced on an IluminaHiSeq2500 platform, and 250 bp paired-end reads were generated.
2.4 16s ribosomal RNA sequence analysis
Raw sequence reads of 16s rRNA gene sequences were filtered and analyzed by vsearch and usearch.28,29 The amplicon sequence variants (ASV, 100 % cluster) were classified taxonomically through Unoise330 and using the Greengenes 16s ribosomal RNA gene reference database. The taxonomic composition of microbial communities was visualized using R and STAMP v.2.1.3, subjected to Benjamini-Hochberg false discovery rate (FDR) correction.
2.5 Principal coordinates analysis (PCoA)
PCoA can simplify the distances of samples from multiple-to two-dimension. Two types of distance matrixes (Bray-Curtis and Unweighted Unifrac) were compared and constrained PCoA (CPCoA) was also performed. These methods were designed to dig out the distinctive distance of each sample group.
2.6 LDA and LEfSe analysis
To identify the distinctive cervical canal microbiota between different groups, linear discriminant analysis (LDA) and LDA Effect Size (LEfSe) method were used to compare the composition of cervical canal microbiota using an online tool (www.ehbio.com). Cladogram, LDA barplot, and proportion histogram were generated.
2.7 Machine learning
Machine learning was emerged as a method to determine how the microbiome can be used to separate samples based on current state or predict future state.31 Random Forest classification contained the predictive bacterial taxa of endometriosis and adenomyosis with 5 folds cross-validation. Visual Analogue Scale (VAS) and menstrual cycle were studied using Random Forest regression with 10 folds cross validation to find out the important taxa in different phases.
2.8 Environment factor analysis
Environment factor analysis was conducted to identify specific factors that correlate to the feature of microbiota using the Adonis test (p < 0.05). We included the number of gravidity and parity, height, weight, body mass index (BMI), days of menstrual period, days of the menstrual cycle, VAS, infertility, gonadotrophin-releasing hormone agonists (GnRH-a) treatment. Variance Partitioning Analysis (VPA) was used to identify the best combination of factors that impact the different features the most.
3 Results
3.1 Demographic
21 (14.09 %) participants were diagnosed adenomyosis without endometriosis, 34 (22.82 %) participants were endometriosis (including ovarian endometriosis, deepDIE, peritoneal type, and other special types) without adenomyosis, 13 (8.72 %) participants were adenomyosis combine with endometriosis, 81 (54.36 %) patients were classified as control group, including infertility, leiomyoma, ovarian borderline tumor and teratoma. In total 298 samples, 67 (22.48 %) samples were endometriosis group (EM), 161 (54.03 %) samples were control group (CT), 27 (9.06 %) samples were adenomyosis-endometriosis group (AMEM) and 43 (14.43 %) samples were adenomyosis group (AM) (Fig. 1 b).
3.2 Microbiota features in group analysis
3.2.1 Microbiota diversity of adenomyosis and endometriosis
The patients were divided into four different groups (AM, AMEM, CT, and EM). The dominant genus of bacteria in the lower genital tract is Lactobacillus, including L.crispatus, L.iners, L. jensenii and L. gasseri.14 Chao index, Richness index, Shannon_e index and Simpson index showed no statistical difference (Fig. 2). The alpha-rarefaction curve was also assessed to validate the depth of sample size (Supplementary Fig. 1). In the beta diversity analysis, the top 10 OTUs (Operational Taxonomy Units) were selected according to abundance and showed in family and genus levels (Fig. 3). AM group shared the largest proportion in Atopobium, adenomyosis-endometriosis took the largest proportion in Gardnerella (Fig. 4). Lactobacillus is still the most dominant OTU as reported,9,13 but for several cases, Lactobacillus only took a small proportion while Gardnerella, Atopobium or Prevotella were significant dominant (Supplementary Fig. 2).
In the Bray-Curtis matrix analysis, AM and AMEM groups were nearly fully overlapped with each other while EM and CT groups were mostly overlapped; four groups of distribution areas with 95 % confidential interval (CI) were almost the same (Fig. 5 a). In the Unweighted-Unifrac matrix, the areas of four groups were not separated distinctively. However, AM groups showed a wider distance than any other groups (Fig. 5 b), and CPCoA almost experienced the same problem (Fig. 5 c).
According to different methods of beta diversity analysis, although the proportion of such OTUs was different in the histogram (Fig. 3 and Supplementary Fig. 2), the groups may still not be separated significantly in the PCoA plot (Fig. 5).
3.3 Distinctive species of different disease groups
The two-two comparison showed significantly distinctive microbiotas (p < 0.05). At family level, only two microbiotas showed differences. The proportion of Peptoniphilaceae was higher in AM and AMEM (Fig. 6 a 2) and shared almost the same proportion in AM-AMEM and EM-CT comparisons (Supplementary Fig. 3 a 2). Enterococcaceae showed no differences between AMEM(n = 27) and EM(n = 67), p = 0.17. In the genus level, Bifidobacterium was significantly higher in AM than any other group. Other microbiotas of Finegoldia and Peptostreptococcus occupied more proportions in the AMEM group (Fig. 6 b 4,5). Enterococcus showed no differences between AMEM(n = 27) and EM(n = 67), p = 0.17; Finegoldia also showed no differences between AMEM(n = 27) and AM(n = 43), p = 0.19. These histograms only analyzed the different proportions of microbiotas, but it could not find out their importance (Fig. 6). The three-dimensional PCA figure also did not show significant differences in four disease groups (Supplementary Fig. 4).
3.4 Possible biomarker of microbiota in the lower genital tract
At the family level, Clostridiales_Incertae_Sedis_XI demonstrated significant distinction with LDA score (log 10) >4.0; in the genus level, Anaerococcus exhibited distinctive importance with LDA score (log 10) >4.0 (Fig. 7, Supplementary Fig. 5). The result of proportional differences in beta diversity did not reveal such characteristics at family level, and the relative abundance of Clostridiales_Incertae_Sedis_XI Anaerococcus displayed significant individual differences (Supplementary Fig. 6).
3.5 Sample site selection and feature importance of microbiota in dysmenorrhea related study
Previous studies have proved that endometriosis dysmenorrhea is correlated to some imbalanced immune factors, such as IL-6 and IL-8,32 but the mechanism is still not fully understood. VAS performed random forest regression to figure out the importance and to change tendency of exact microbiota through heat maps. Two sites of sample collection (cervical canal & posterior fornix) were compared with each other. By selecting the OTU number that could minimize the error rate (Supplementary Fig. 7), the corresponding top number of microbiotas were selected, and their feature importance was calculated, respectively (Fig. 8 a-d). Nearly half of the microbiota contributed to negative InMSE (increased in mean squared error %) in site A (Fig. 8 a,c), while all the OTUs at site B showed positive InMSE (Fig. 8 b,d). These result suggested that the posterior fornix could be a better sampling site than the cervical canal to evaluate dysmenorrhea-related microbiota in both family and genus levels.
In addition, the important features of the heat map were also generated (Fig. 9 a-d). In the samples at site B, the important features of microbiota changed from upper left to lower right with the increase of VAS (Fig. 9 b,d), suggesting that VAS is associated with the important change of microbiota.
3.6 Menstrual cycle-related microbiota shift in endometriosis and adenomyosis
Random forest regression was also used to analyze the microbiota features during the menstrual cycle. Estrogen is associated with interleukin (IL)33 as well as macrophages34; the change of IL is also correlated to the bacterial micro-environment.10 The microbiotas that impact the micro-environment the most are shown in Supplementary Figs. 8 and 9. GnRH-a-treated patients were excluded (n = 27). For the adenomyosis patients (n = 35), Erysipelotrichaceae was the most important bacteria in the posterior fornix of vagina (Supplementary Figure 8 b). While for the endometriosis patients, Clostridiaceae and Mycoplasmataceae were the most important ones in the cervical canal and posterior fornix, respectively (Supplementary Figs. 9a–b). Heat maps show the microbiota change within the menstrual cycle (Figs. 10 and 11).
3.7 Environmental factors contributing to the microbiota features
Adonis test showed that eight factors were significantly related to microbiota feature, gravidity, parity, weight, BMI, menstrual cycle, VAS, infertility, and GnRH-a treatment (p < 0.05). GnRH-a was the most important factor that contributes to the feature differences between microbiota (Table 1). In addition, the different combinations of those factors also contributed to the differences to various extent; the VPA result demonstrated that the single factor of GnRH-a was the most relative, while the other combinations were not important as GnRH-a (Fig. 12). CCA showed how those significant factors affected the microbiota features. The vector of GnRH-a was the longest, indicating that GnRH-a treatment is the most effective factor (Fig. 13). Infertility, dysmenorrhea, and the menstrual cycle had similar effects on microbiota features.
4 Discussion
This pilot study focused on the microbiota feature and diagnostic model of endometriosis and adenomyosis. Although the microbiota in uterine cavity has been studied, the results and methods of those studies were miscellaneous; not all researchers were able to obtain a clear conclusion due to potential contaminations or infection.11–13,18,35 It is still debatable whether the uterine cavity is sterilized, in other words, whether bacterial contamination only occurs in specific situations, such as in hyper-contraction phases of the uterus36 or post-GnRH-a treatment.37 The PCR results of our samples from the uterine cavity were unsatisfactory, suggesting that some of the uterine cavities were bacteria-free, and the real condition and the exact situation can be more complicated. Moreover, the potential contamination cannot be excluded. In addition, due to the limited methods to collect samples, contamination may occur in sampling, as J.Baker et al. mentioned.18 C.Chen et al. collected the samples from the upper genital tract during operation, but the intra-operational antibiotic usage may affect the final result of the study.13
Since intra-uterine and cervical microbiotas features have not been demonstrated, the microbiotas near the cervix were investigated instead of the endometrium. Two locations were included, i.e., cervical canal and posterior fornix of the vagina. Although these two sites cannot fully represent the whole community in genital tract, they are the closest sites to the endometrium, and these two sites are easily accessible. A better sampling location was expected to proceed with the analysis and minimize the error of microbiota analysis. The investigation on dysmenorrhea by random forest regression identified the importance of the features of microbiota. The cervical canal samples displayed more OTUs with negative impacts, while the posterior fornix samples showed several OTUs with only positive impacts. It proved that posterior fornix is a better sampling location to analyze the microbiota feature in dysmenorrhea investigation.
We divided the participants into four groups, AM, EM, AMEM and CT. It is noteworthy that the different proportions in beta diversity do not completely stand for statistical differences. Only one microbiota, Clostridiales_Incertae_Sedis_XI Anaerococcus, was identified as a biomarker in AMEM patients. Anaerococcus was not significantly different in statistical analysis (p > 0.05), but LeFSe analysis includes comprehensive algorithms of all OTU features, and was identified as a potential biomarker. Genus Anaerococcus was first identified in 2001 by Ezaki,37 a common colonized bacteria in the gut and women's genital tract.38–40
In beta diversity, Atopobium took more proportion in AMEM patients in our study, compared with the low abundance in AM or EM. Atopobium is an endometrial cancer-related bacteria, but whether it can facilitate malignancy from adenomyosis or endometriosis through downstream effect is unknown.41 In addition, Atopobium is also a BV-related bacterium, and sub-clinical infection of BV may affect the microbiota feature analysis. Thus, it may not be a better point of endometriosis compared with Anaerococcus. In some other cases, the BV-related bacteria, such as Atopobium, Gardenerella and Prevotella, can also act as dominant ones in the vagina; similar results were also reported by F.Polatti and K.Murphy et al.10,30
The abundance and functions of microbiota is different between secretory and proliferating phase.13 Herein, the importance index (InMSE) of microbiota during the whole menstrual cycle were analyzed. Using heat map, each microbiota could be recognized as only important in specific days during the period, while a few bacteria even had a negative importance index. Different study levels and sampling sites also showed different results.
Environmental factors analysis is aimed to find out the possible factors that impact the microbiota features and how they impact the features. Ten factors that have been routinely recorded in medical records were included, but different live styles and other unknown factors were not traceable. Since now there are no quantitative measurement of sexual activity, so we included gravidity and parity as two possible variants to represent sexual activity in this study. Eight environmental factors were statistically significant with p < 0.05. GnRH-a treatment was the most critical factor influencing the microbiota feature, followed by BMI and weight, but each led to different feature characteristics of the microbiotas. Infertility, days of menstrual cycle and dysmenorrhea showed similar effectiveness in different extents. For GnRH-a-treated patients, their vaginal environments were similar to post-menopause women, and bacterial contamination can be detected in the uterine cavity and endometriosis cystic fluid.37 Infertility, menstrual cycle, and GnRH-a treatment are all associated with ovarian function; previous research has also demonstrated that estrogen and macrophages' cross talk contributes to endometriosis dysmenorrhea.34 These findings indicated that the microbiota feature is correlated to estrogen level or ovarian function. The exact mechanism will be identified in future studies. All considered, the factors only contribute to the feature for less than 2 %, according to the Adonis test, which means that other unknown factors should determine the feature of microbiota for more than 98 %.
5 Conclusion
In this paper, the microbiota feature and differences among endometriosis and adenomyosis patients were discussed. Because there is no valid consensus that the uterine cavity is bacteria-free or not, the microbiotas from the cervical canal and posterior fornix were compared to find out a better sampling site that could represent the feature of diseases. Our findings proved that the posterior fornix of vagina was a better site to analyze dysmenorrhea. A few bacteria were identified as important microbiota in different phases of the menstrual cycle. Anaerococcus was defined as the biomarker of adenomyosis-endometriosis patients in both family and genus levels. GnRH-a was the most critical environmental factor that impacts microbiota, while other environmental factors also contributed to the variety of features in different extent. In addition, biomarker identification may contribute to a new method of non-invasive diagnosis, and bacterial transplantation will be a possible therapy in the future.
Authors' contributions
Sample collection: Sikai Chen, Zhiyue Gu, Wen Zhang, Ping Zheng.
Investigation: Sikai Chen.
Data analysis: Sikai Chen.
Data visualization: Chen Sikai, Zhiyue Gu.
Writing of original draft: Sikai Chen, Zhiyue Gu.
Writing-review and editing: Sikai Chen, Shuangzheng Jia, Yi Dai.
Final Approval of manuscript: Jinhua Leng, Yi Dai.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
The study was funded by The Ministry of Science and Technology of the People’s Republic of China, National Program on Key Basic Research Project of China (2017YFC1001200).
The authors appreciated the First Gynecological Ward and Forth Gynecological Ward nurses in Peking Union Medical College Hospital for their co-operation of sample collection before surgery preparation.
Jie Guo from CIO Office of Tsing Hua University conducted the color design of circulized-plot.
The author appreciated Ehbio Gene Technology Co. Ltd (Beijing, China) for providing sequencing analysis methodology and platforms. The authors are very grateful to the Annoroad Gene Technology Co. Ltd (Beijing, China) for their help in 16S ribosomal-RNA gene sequencing.
Appendix
Appendix A Supplementary data
The following are the Supplementary data to this article:
Multimedia component 1
Multimedia component 2
Appendix A Supplementary data
Supplementary data to this article can be found online at https://doi.org/10.1016/j.gocm.2021.07.007.
References
Footnotes
↵1 Sikai Chen and Zhiyue Gu contributed equally to this work